{"id":"https://openalex.org/W2210172852","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.3530","title":"Lack of effect of bevacizumab on wound healing/bleeding complications when given 28\u201360 days following primary cancer surgery","display_name":"Lack of effect of bevacizumab on wound healing/bleeding complications when given 28\u201360 days following primary cancer surgery","alternate_titles":[],"publication_year":2004,"publication_date":"2004-07-15","ids":{"openalex":"https://openalex.org/W2210172852","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.3530","mag":"2210172852"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2004.22.14_suppl.3530","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.3530","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.14_suppl.3530","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2210172852"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015225025","display_name":"Frank A. Scappaticci","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]},{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"F. Scappaticci","raw_affiliation_strings":["Genentech, Inc, South San Francisco, CA; Kaiser Permanente, Vallejo, CA; US Oncology, Ocala, CA; Sarah Cannon Cancer Center, Nashville, TN; Heme/Onc Associates of Northeast Pennsylvania, Scranton, PA; Vanderbilt University, Nashville, TN; UCLA, Los Angeles, CA; Duke University, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc, South San Francisco, CA; Kaiser Permanente, Vallejo, CA; US Oncology, Ocala, CA; Sarah Cannon Cancer Center, Nashville, TN; Heme/Onc Associates of Northeast Pennsylvania, Scranton, PA; Vanderbilt University, Nashville, TN; UCLA, Los Angeles, CA; Duke University, Durham, NC","institution_ids":["https://openalex.org/I1343052199","https://openalex.org/I161318765","https://openalex.org/I170897317","https://openalex.org/I183934855","https://openalex.org/I200719446","https://openalex.org/I4210100810"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089385120","display_name":"Lou Fehrenbacher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]},{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Fehrenbacher","raw_affiliation_strings":["Genentech, Inc, South San Francisco, CA; Kaiser Permanente, Vallejo, CA; US Oncology, Ocala, CA; Sarah Cannon Cancer Center, Nashville, TN; Heme/Onc Associates of Northeast Pennsylvania, Scranton, PA; Vanderbilt University, Nashville, TN; UCLA, Los Angeles, CA; Duke University, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc, South San Francisco, CA; Kaiser Permanente, Vallejo, CA; US Oncology, Ocala, CA; Sarah Cannon Cancer Center, Nashville, TN; Heme/Onc Associates of Northeast Pennsylvania, Scranton, PA; Vanderbilt University, Nashville, TN; UCLA, Los Angeles, CA; Duke University, Durham, NC","institution_ids":["https://openalex.org/I1343052199","https://openalex.org/I161318765","https://openalex.org/I170897317","https://openalex.org/I183934855","https://openalex.org/I200719446","https://openalex.org/I4210100810"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074776719","display_name":"Thomas H. Cartwright","orcid":"https://orcid.org/0000-0002-7980-4233","observed_orcids":["https://orcid.org/0000-0002-7980-4233"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]},{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Cartwright","raw_affiliation_strings":["Genentech, Inc, South San Francisco, CA; Kaiser Permanente, Vallejo, CA; US Oncology, Ocala, CA; Sarah Cannon Cancer Center, Nashville, TN; Heme/Onc Associates of Northeast Pennsylvania, Scranton, PA; Vanderbilt University, Nashville, TN; UCLA, Los Angeles, CA; Duke University, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc, South San Francisco, CA; Kaiser Permanente, Vallejo, CA; US Oncology, Ocala, CA; Sarah Cannon Cancer Center, Nashville, TN; Heme/Onc Associates of Northeast Pennsylvania, Scranton, PA; Vanderbilt University, Nashville, TN; UCLA, Los Angeles, CA; Duke University, Durham, NC","institution_ids":["https://openalex.org/I1343052199","https://openalex.org/I161318765","https://openalex.org/I170897317","https://openalex.org/I183934855","https://openalex.org/I200719446","https://openalex.org/I4210100810"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065917441","display_name":"John Daniel Hainsworth","orcid":"https://orcid.org/0000-0002-2848-6546","observed_orcids":["https://orcid.org/0000-0002-2848-6546"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]},{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Hainsworth","raw_affiliation_strings":["Genentech, Inc, South San Francisco, CA; Kaiser Permanente, Vallejo, CA; US Oncology, Ocala, CA; Sarah Cannon Cancer Center, Nashville, TN; Heme/Onc Associates of Northeast Pennsylvania, Scranton, PA; Vanderbilt University, Nashville, TN; UCLA, Los Angeles, CA; Duke University, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc, South San Francisco, CA; Kaiser Permanente, Vallejo, CA; US Oncology, Ocala, CA; Sarah Cannon Cancer Center, Nashville, TN; Heme/Onc Associates of Northeast Pennsylvania, Scranton, PA; Vanderbilt University, Nashville, TN; UCLA, Los Angeles, CA; Duke University, Durham, NC","institution_ids":["https://openalex.org/I1343052199","https://openalex.org/I161318765","https://openalex.org/I170897317","https://openalex.org/I183934855","https://openalex.org/I200719446","https://openalex.org/I4210100810"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077135968","display_name":"William J. Heim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]},{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. Heim","raw_affiliation_strings":["Genentech, Inc, South San Francisco, CA; Kaiser Permanente, Vallejo, CA; US Oncology, Ocala, CA; Sarah Cannon Cancer Center, Nashville, TN; Heme/Onc Associates of Northeast Pennsylvania, Scranton, PA; Vanderbilt University, Nashville, TN; UCLA, Los Angeles, CA; Duke University, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc, South San Francisco, CA; Kaiser Permanente, Vallejo, CA; US Oncology, Ocala, CA; Sarah Cannon Cancer Center, Nashville, TN; Heme/Onc Associates of Northeast Pennsylvania, Scranton, PA; Vanderbilt University, Nashville, TN; UCLA, Los Angeles, CA; Duke University, Durham, NC","institution_ids":["https://openalex.org/I1343052199","https://openalex.org/I161318765","https://openalex.org/I170897317","https://openalex.org/I183934855","https://openalex.org/I200719446","https://openalex.org/I4210100810"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039492614","display_name":"Jordan D. Berlin","orcid":"https://orcid.org/0000-0001-7571-2385","observed_orcids":["https://orcid.org/0000-0001-7571-2385"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]},{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Berlin","raw_affiliation_strings":["Genentech, Inc, South San Francisco, CA; Kaiser Permanente, Vallejo, CA; US Oncology, Ocala, CA; Sarah Cannon Cancer Center, Nashville, TN; Heme/Onc Associates of Northeast Pennsylvania, Scranton, PA; Vanderbilt University, Nashville, TN; UCLA, Los Angeles, CA; Duke University, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc, South San Francisco, CA; Kaiser Permanente, Vallejo, CA; US Oncology, Ocala, CA; Sarah Cannon Cancer Center, Nashville, TN; Heme/Onc Associates of Northeast Pennsylvania, Scranton, PA; Vanderbilt University, Nashville, TN; UCLA, Los Angeles, CA; Duke University, Durham, NC","institution_ids":["https://openalex.org/I1343052199","https://openalex.org/I161318765","https://openalex.org/I170897317","https://openalex.org/I183934855","https://openalex.org/I200719446","https://openalex.org/I4210100810"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006496749","display_name":"Fairooz F. Kabbinavar","orcid":"https://orcid.org/0009-0003-2552-4935","observed_orcids":["https://orcid.org/0009-0003-2552-4935"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]},{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"F. Kabbinavar","raw_affiliation_strings":["Genentech, Inc, South San Francisco, CA; Kaiser Permanente, Vallejo, CA; US Oncology, Ocala, CA; Sarah Cannon Cancer Center, Nashville, TN; Heme/Onc Associates of Northeast Pennsylvania, Scranton, PA; Vanderbilt University, Nashville, TN; UCLA, Los Angeles, CA; Duke University, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc, South San Francisco, CA; Kaiser Permanente, Vallejo, CA; US Oncology, Ocala, CA; Sarah Cannon Cancer Center, Nashville, TN; Heme/Onc Associates of Northeast Pennsylvania, Scranton, PA; Vanderbilt University, Nashville, TN; UCLA, Los Angeles, CA; Duke University, Durham, NC","institution_ids":["https://openalex.org/I1343052199","https://openalex.org/I161318765","https://openalex.org/I170897317","https://openalex.org/I183934855","https://openalex.org/I200719446","https://openalex.org/I4210100810"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060799552","display_name":"William F. Novotny","orcid":"https://orcid.org/0009-0000-3857-9829","observed_orcids":["https://orcid.org/0009-0000-3857-9829"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]},{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. Novotny","raw_affiliation_strings":["Genentech, Inc, South San Francisco, CA; Kaiser Permanente, Vallejo, CA; US Oncology, Ocala, CA; Sarah Cannon Cancer Center, Nashville, TN; Heme/Onc Associates of Northeast Pennsylvania, Scranton, PA; Vanderbilt University, Nashville, TN; UCLA, Los Angeles, CA; Duke University, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc, South San Francisco, CA; Kaiser Permanente, Vallejo, CA; US Oncology, Ocala, CA; Sarah Cannon Cancer Center, Nashville, TN; Heme/Onc Associates of Northeast Pennsylvania, Scranton, PA; Vanderbilt University, Nashville, TN; UCLA, Los Angeles, CA; Duke University, Durham, NC","institution_ids":["https://openalex.org/I1343052199","https://openalex.org/I161318765","https://openalex.org/I170897317","https://openalex.org/I183934855","https://openalex.org/I200719446","https://openalex.org/I4210100810"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046311492","display_name":"Herbert I. Hurwitz","orcid":"https://orcid.org/0000-0003-3242-9197","observed_orcids":["https://orcid.org/0000-0003-3242-9197"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]},{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H. Hurwitz","raw_affiliation_strings":["Genentech, Inc, South San Francisco, CA; Kaiser Permanente, Vallejo, CA; US Oncology, Ocala, CA; Sarah Cannon Cancer Center, Nashville, TN; Heme/Onc Associates of Northeast Pennsylvania, Scranton, PA; Vanderbilt University, Nashville, TN; UCLA, Los Angeles, CA; Duke University, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc, South San Francisco, CA; Kaiser Permanente, Vallejo, CA; US Oncology, Ocala, CA; Sarah Cannon Cancer Center, Nashville, TN; Heme/Onc Associates of Northeast Pennsylvania, Scranton, PA; Vanderbilt University, Nashville, TN; UCLA, Los Angeles, CA; Duke University, Durham, NC","institution_ids":["https://openalex.org/I1343052199","https://openalex.org/I161318765","https://openalex.org/I170897317","https://openalex.org/I183934855","https://openalex.org/I200719446","https://openalex.org/I4210100810"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":"14_suppl","first_page":"3530","last_page":"3530"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.6449999809265137,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.6449999809265137,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.21369999647140503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":0.0746999979019165,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":1.0},{"id":"https://openalex.org/keywords/wound-healing","display_name":"wound healing","score":0.7879999876022339},{"id":"https://openalex.org/keywords/postoperative-bleeding-complications","display_name":"postoperative bleeding complications","score":0.8130000233650208},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.6389999985694885},{"id":"https://openalex.org/keywords/rectal-cancer","display_name":"rectal cancer","score":0.5920000076293945},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.6299999952316284},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.8730000257492065},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.9079999923706055},{"id":"https://openalex.org/keywords/leucovorin","display_name":"leucovorin","score":0.8059999942779541},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.6959999799728394},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.7329999804496765},{"id":"https://openalex.org/keywords/wound-dehiscence","display_name":"wound dehiscence","score":0.7160000205039978}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.976125955581665},{"id":"https://openalex.org/C43376680","wikidata":"https://www.wikidata.org/wiki/Q6580786","display_name":"Bolus (digestion)","level":2,"score":0.7696170806884766},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.7225650548934937},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.6344760656356812},{"id":"https://openalex.org/C2780269544","wikidata":"https://www.wikidata.org/wiki/Q1509074","display_name":"Wound healing","level":2,"score":0.5954776406288147},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.4885016679763794},{"id":"https://openalex.org/C2780664938","wikidata":"https://www.wikidata.org/wiki/Q1398178","display_name":"Wound dehiscence","level":2,"score":0.42307764291763306},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3699136972427368},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.318397581577301},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.14363673329353333}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2004.22.14_suppl.3530","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.3530","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.14_suppl.3530","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"doi:10.1200/jco.2004.22.90140.3530","doi":"https://doi.org/10.1200/jco.2004.22.90140.3530","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.90140.3530","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2530098706","https://openalex.org/W2033597946","https://openalex.org/W2006561878","https://openalex.org/W2064680741","https://openalex.org/W2322241559","https://openalex.org/W2949210429","https://openalex.org/W49207905","https://openalex.org/W2531523762","https://openalex.org/W2329817084","https://openalex.org/W2040773806"],"abstract_inverted_index":{"3530":[0],"Background:":[1],"Bevacizumab":[2],"[Avastin":[3],"(BV)]":[4],"is":[5],"a":[6,234],"humanized":[7],"monoclonal":[8],"antibody":[9],"directed":[10],"against":[11],"vascular":[12],"endothelial":[13],"growth":[14],"factor.":[15],"A":[16,131],"recent":[17],"randomized,":[18],"double-blinded,":[19],"Phase":[20],"III":[21],"trial":[22],"showed":[23],"that":[24,74,217],"addition":[25],"of":[26,58,105,133,155,170,228,238,252],"Avastin":[27,229,253],"to":[28,99,233],"chemotherapy":[29,158],"(bolus":[30],"irinotecan,":[31],"5-FU,":[32],"leucovorin":[33],"-IFL)":[34],"increased":[35,236],"survival":[36],"compared":[37,159],"with":[38,160],"IFL":[39,67,77,140,166,189,201],"alone.":[40,78,167],"Antiangiogenic":[41],"therapy":[42],"has":[43],"previously":[44],"shown":[45],"delay":[46],"in":[47,50,61,87,179,186,196,208,219,254],"wound":[48,59,117,120,175,239],"healing":[49,60,81,176,240],"preclinical":[51],"models.":[52],"Therefore,":[53],"we":[54],"undertook":[55],"an":[56],"analysis":[57],"subjects":[62,88,135,143,162,180,193,205,220],"receiving":[63,136,144],"BV":[64,69,137,145,156,198,210],"plus":[65,70,138,146,157],"bolus":[66,76,139,165,188,200],"and":[68,82,126,141,203],"5-FU/LV":[71,147,212],"versus":[72],"those":[73],"received":[75,164],"Methods:":[79],"Wound":[80],"bleeding":[83,178,242],"complications":[84],"were":[85,128],"analyzed":[86],"who":[89,163],"underwent":[90,148],"primary":[91],"cancer":[92,150],"surgery":[93,151,218],"(i.e.,":[94],"colonic":[95],"or":[96,261,264],"rectal":[97],"resection":[98],"remove":[100],"tumor)":[101],"within":[102,221],"28\u201360":[103,222],"days":[104,223],"starting":[106],"study":[107],"treatment.":[108],"Sixty-day":[109],"post-operative":[110],"adverse":[111],"events":[112],"reported":[113],"as":[114],"abnormal":[115],"healing,":[116,121],"dehiscence,":[118],"delayed":[119],"bowel":[122],"perforation,":[123],"fistula,":[124],"abscess,":[125],"hemorrhage":[127],"studied.":[129],"Results:":[130],"total":[132],"150":[134],"37":[142],"prior":[149],"before":[152,224],"initial":[153,226],"use":[154,227],"155":[161],"The":[168],"incidence":[169,237],"Grade":[171],"3":[172,192],"/":[173,177,241],"4":[174],"was":[181],"1":[182],"subject":[183],"(0.65":[184],"%)":[185,195,207],"the":[187,197,209,225,249],"arm":[190],"alone,":[191],"(2.0":[194],"+":[199,211],"arm,":[202],"no":[204],"(0":[206],"arm.":[213],"Conclusions:These":[214],"results":[215,245],"suggest":[216],"does":[230],"not":[231],"lead":[232],"significantly":[235],"complications.":[243],"These":[244],"are":[246],"encouraging":[247],"for":[248],"planned":[250],"evaluation":[251],"adjuvant":[255],"colorectal":[256],"trials.":[257],"Author":[258],"Disclosure":[259],"Employment":[260],"Leadership":[262],"Consultant":[263],"Advisory":[265],"Stock":[266],"Ownership":[267],"Honoraria":[268],"Research":[269],"Funding":[270],"Expert":[271],"Testimony":[272],"Other":[273],"Remuneration":[274],"Genentech":[275,280,281],"Bais;":[276],"Genentech;":[277,282],"Pfizer;":[278,284],"USON":[279],"GlaxoSmithKline;":[283],"Roche":[285]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2210172852","counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2016-06-24T00:00:00"}
